Moderna to bolster commercial footprint in Europe
Joe Raedle/Getty Images News


Moderna (NASDAQ:MRNA) plans to expand its commercial network in six additional countries in Europe.
Moderna (MRNA) aims to set up a commercial presence in Belgium, Denmark, Norway, the Netherlands, Poland, and Sweden to support the delivery of mRNA vaccines and therapeutics locally.

The company already has subsidiaries in Italy, France, Germany, Spain, Switzerland, and the U.K. Moderna Poland, which hosts the Moderna International Business Services Center, will also expand to provide commercial capabilities.
Earlier in the week, the company announced plans to set up new subsidiaries in Asia and also expanded a partnership with Spain's Rovi to manufacture MRNA medicines.
MRNA -0.99% premarket to $150.30